Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 291 to 300 of 1525

TitleReference numberPublishedLast updated
Upadacitinib for previously treated moderately to severely active Crohn's diseaseTA905
Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fractionTA902
Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancerTA903
MiraQ cardiac TTFM with high-frequency probe for assessing graft flow during coronary artery bypass graft surgeryMIB323
Cemiplimab for treating recurrent or metastatic cervical cancer (terminated appraisal)TA901
Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancerTA898
Tixagevimab plus cilgavimab for preventing COVID-19TA900
YOURmeds for medication support in long-term conditionsMIB289
FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist careHTG682
Brexucabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 26 years and overTA893

Results per page

  1. 10
  2. 25
  3. 50
  4. All